Nora Ian, Shridhar Ravi, Meredith Kenneth
Graduate Entry Medical School, University of Limerick, Limerick, Ireland.
Central Florida University, Orlando.
Robot Surg. 2017 Sep 27;4:93-100. doi: 10.2147/RSRR.S99537. eCollection 2017.
Esophagectomy is pivotal for the long-term survival in patients with early stage and advanced esophageal cancer, and improved perioperative care and advanced surgical techniques have contributed to reduced postoperative morbidity. However, despite these advances, esophagectomy continues to be associated with significant morbidity and mortality. Minimally invasive esophageal surgery (MIE) has been increasingly used in patients undergoing surgery for esophageal cancer. Potential advantages of MIE include the decreased postoperative pain; lower postoperative wound infection, decreased pulmonary complications, and decreased length of hospitalization. Robotic esophageal surgery has the ability to overcome some of the limitations of laparoscopic and thoracoscopic approaches to esophagectomy while maintaining the benefits of the minimally invasive approach. In this article, we will review the clinical efficacy and outcomes associated with robotic-assisted Ivor Lewis esophagectomy (RAIL).
食管癌切除术对于早期和晚期食管癌患者的长期生存至关重要，围手术期护理的改善和先进的手术技术有助于降低术后发病率。然而，尽管有这些进展，食管癌切除术仍然与显著的发病率和死亡率相关。微创食管手术（MIE）越来越多地用于接受食管癌手术的患者。MIE的潜在优势包括术后疼痛减轻；术后伤口感染率降低、肺部并发症减少以及住院时间缩短。机器人食管手术能够克服腹腔镜和胸腔镜食管癌切除方法的一些局限性，同时保持微创方法的益处。在本文中，我们将回顾机器人辅助Ivor Lewis食管癌切除术（RAIL）的临床疗效和结果。
